Page last updated: 2024-08-21

dronabinol and Carcinoma, Ovarian Epithelial

dronabinol has been researched along with Carcinoma, Ovarian Epithelial in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Anil, SM; Belausov, E; Kendall, M; Koltai, H; Kumar, N; Peeri, H; Shalev, N; Tiwari, S; Vinayaka, AC1

Other Studies

1 other study(ies) available for dronabinol and Carcinoma, Ovarian Epithelial

ArticleYear
Phytocannabinoid Compositions from Cannabis Act Synergistically with PARP1 Inhibitor against Ovarian Cancer Cells In Vitro and Affect the Wnt Signaling Pathway.
    Molecules (Basel, Switzerland), 2022, Nov-03, Volume: 27, Issue:21

    Topics: Cannabinoid Receptor Agonists; Cannabis; Carcinoma, Ovarian Epithelial; Dronabinol; Female; Hallucinogens; Humans; Ovarian Neoplasms; Poly (ADP-Ribose) Polymerase-1; Wnt Signaling Pathway

2022